Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle
Open Access

The Regional-Specific Relative and Absolute Expression of Gut Transporters in Adult Caucasians: A Meta-Analysis

Matthew D. Harwood, Mian Zhang, Shriram M. Pathak and Sibylle Neuhoff
Drug Metabolism and Disposition August 2019, 47 (8) 854-864; DOI: https://doi.org/10.1124/dmd.119.086959
Matthew D. Harwood
Certara UK Ltd., Simcyp Division, Sheffield, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew D. Harwood
Mian Zhang
Certara UK Ltd., Simcyp Division, Sheffield, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mian Zhang
Shriram M. Pathak
Certara UK Ltd., Simcyp Division, Sheffield, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shriram M. Pathak
Sibylle Neuhoff
Certara UK Ltd., Simcyp Division, Sheffield, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sibylle Neuhoff
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Exclusion criteria applied to the complete database for the absolute (left) and relative (right) abundance data. Percentages for each exclusion criterion refer to the fraction of the samples in the complete database that were excluded on its basis.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Absolute abundance quantification of ATP-binding cassette (ABC) transporters normalized to the jejunum I segment (A) and solute carrier (SLC) family transporters (B) in all intestinal segments representing the ADAM model (C, colon; D, duodenum; I1–I4, ileum I1–I4 segments; J1 and J2, jejunum I and II segments). Relative abundance quantification of ABC transporters normalized to the jejunum I (C) and SLC transporters (D) in all intestinal segments representing the ADAM and M-ADAM models. The bars represent the weighted mean normalized abundance of each transporter. Representative values depicted in this figure are provided in Supplemental Table 3. Where no abundance data were available a zero value was assigned. This is represented in histogram B for SLC51A/B in all segments except jejunum II and ileum IV and in histogram D for SLC2A2 in all segments except duodenum, SLCO4C1 duodenum, and jejunum I and II. The values provided above the bars for SLC10A2 in histogram B represent the scaled up expression relative to the break point [(//), i.e., 5] executed for these values.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Intestinal drug transporter pies. Proximal jejunum (jejunum I) ATP-binding cassette (ABC) (A) and solute carrier (SLC) and OATP (SLCO) (B). Distal ileum (ileum IV) ABC (C) and SLC and OATP (SLCO) (D). Protein abundance in the final subdatabase for each transporter family transporters as a percentage of the total abundance (in picomoles) of the region shown after performing a simulation with 2000 North European Caucasians.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    The 16 transporters selected for inclusion into the meta-analysis after exclusion criteria were applied to determine region-specific transporter expression in the ADAM and M-ADAM models

    ProteinMembrane LocalizationFunctionalityQuantification (Relative/Absolute)a
    SLC10A2 (IBAT)ApicalUptakeRelative and absolute
    SLC15A1 (PEPT1)ApicalUptakeRelative and absolute
    SLC16A1 (MCT1)ApicalUptakeRelative
    SLCO2B1 (OATP2B1)ApicalUptakeRelative and absolute
    SLC22A1 (OCT1)ApicalUptakeRelative and absolute
    SLC22A3 (OCT3)ApicalUptakeRelative and absolute
    SLC22A4 (OCTN1)ApicalUptakeRelative
    ABCB1 (P-gp)ApicalEffluxRelative and absoluteb
    ABCC2 (MRP2)ApicalEffluxRelative and absoluteb
    ABCG2 (BCRP)ApicalEffluxRelative and absoluteb
    SLC2A2 (GLUT2)BasolateralcUptakeRelative
    SLCO4C1 (OATP4C1)BasolateralcUptakeRelative
    SLC51A/B (OST-α/β)BasolateralcEffluxRelative and absoluted
    ABCC1 (MRP1)BasolateralcEffluxRelative
    ABCC3 (MRP3)BasolateralcEffluxRelative and absolute
    ABCC4 (MRP4)BasolateralcEffluxRelative
    • BCRP, breast cancer resistance protein; MCT1, monocarboxylate transporter 1; PEPT1, peptide transporter 1.

    • ↵a Relates to data available and collated in the final database (i.e., without exclusion criteria applied) (see Fig. 1) for a transporter.

    • ↵b A substantial meta-analysis for relative expression of P-gp, MRP2, and BCRP had already been performed, and the results are published in Harwood et al. (2013).

    • ↵c Note that the M-ADAM model requires selection to enable activation of the basolateral membrane localized transporters.

    • ↵d Data collated distinctly for α (SLC51A) and β (SLC51B) subunits, hence counted as individual transporters in the Fig. 1 count of transporter data collated.

    • View popup
    TABLE 2

    The weighted mean, coefficient of variation, and geometric mean of total membrane protein abundance of drug transporters in the proximal jejunum (jejunum I) obtained from the meta-analysis of measurements in tissue of healthy Caucasian adults

    TransporterMeanaCVGeometric MeanaNumber of SamplesNumber of StudiesHeterogeneityReference
    PYes/No
    %
    ABCB1 (P-gp)0.4440.371130.98NoGröer et al. (2013), Oswald et al. (2013), Drozdzik et al. (2014)
    ABCC2 (MRP2)0.86680.711130.82NoGröer et al. (2013), Oswald et al. (2013), Drozdzik et al. (2014)
    ABCC3 (MRP3)0.58640.4972N/AbN/AbGröer et al. (2013), Drozdzik et al. (2014)
    ABCG2 (BCRP)0.34620.291130.93NoGröer et al. (2013), Oswald et al. (2013), Drozdzik et al. (2014)
    SLC10A2 (ASBT/IBAT)0.0143c0.0161N/AbN/AbDrozdzik et al. (2014)
    SLC15A1 (PepT1)3.69413.411130.92N/AbGröer et al. (2013), Oswald et al. (2013), Drozdzik et al. (2014)
    SLCO2B1 (OATP2B1)0.4740.321130.57NoGröer et al. (2013), Oswald et al. (2013), Drozdzik et al. (2014)
    SLC22A1 (OCT1)0.65490.5861N/AbN/AbDrozdzik et al. (2014)
    SLC22A3 (OCT3)0.06740.0561N/AbN/AbDrozdzik et al. (2014)
    SLC51A/B (OST-α/β)0.47d99d0.4711N/AbN/AbHarwood (2015)
    • ASBT, apical sodium-dependent bile acid transporter; BCRP, breast cancer resistance protein; N/A, not applicable; PepT1, peptide transporter 1.

    • ↵a Values are given as picomoles per milligram of total membrane protein.

    • ↵b Heterogeneity reporting is not applicable with only one or two studies, when considering subtracting the degree of freedom component (i.e., n minus one study).

    • ↵c The final CV value for jejunum I SLC10A2 was taken from Hilgendorf et al. (2007), based on jejunum mRNA data since it was determined that low abundance levels could give rise to inflated interindividual variability due to analytical imprecision at such low levels of expression.

    • ↵d For OST-α/β, the mean abundance is from a distal jejunum sample and is based on the α-subunit data considering the rate-limiting component for conferring OST-α/β activity (Sun et al., 2007). Also, only a single sample was available; therefore, the CV value was obtained from a combined analysis of jejunum samples from relative and absolute data.

    • View popup
    TABLE 3

    Final region-specific abundances along the gastrointestinal tract normalized to jejunum I based on relative abundance quantification or by combining abundance data obtained from relative and absolute quantification methodology

    ProteinADAM Model Segment (Sample Number Quantified Is Given in Parentheses)Reference
    DuodenumJejunum IaJejunum IIIleum IIleum IIIleum IIIIleum IVColon
    ABCB1 (P-gp)b,c0.51 (31)1 (9)1.46 (8)1.50 (42)1.51 (42)1.52 (42)1.51 (42)0.57 (27)See Table 2 in Harwood et al. (2013) for references
    ABCC1 (MRP1)b0.45 (37)1 (9)0.88 (9)0.86 (37)0.86 (37)0.89 (37)0.89 (37)0.93 (50)Fromm et al. (2000), Albermann et al. (2005), Zimmermann et al. (2005), Berggren et al. (2007), Blokzijl et al. (2007), Bourgine et al. (2012), Drozdzik et al. (2014)
    ABCC2 (MRP2)b,c1.41 (71)1 (4)1 (4)0.60 (41)0.60 (41)0.60 (41)0.60 (41)0.02 (26)See Table 2 in Harwood et al. (2013) for references
    ABCC3 (MRP3)2.15 (29)1 (16)0.89 (16)1.54 (35)1.54 (35)1.60 (35)1.60 (35)5.95 (35)Zimmermann et al. (2005), Englund et al. (2006), Seithel et al. (2006), Bourgine et al. (2012), Gröer et al. (2013), Drozdzik et al. (2014)
    ABCC4 (MRP4)b1.02 (15)1 (6)1.22 (6)1.71 (19)1.71 (19)1.20 (19)1.20 (19)1.76 (19)Zimmermann et al. (2005), Bourgine et al. (2012), Drozdzik et al. (2014)
    ABCG2 (BCRP)b,c0.47 (45)1 (14)1 (45)0.59 (45)0.59 (45)0.59 (45)0.59 (45)0.13 (35)See Table 2 in Harwood et al. (2013) for references
    SLC2A2 (GLUT2)b1 (15)1 (0)d1 (0)d1 (0)d1 (0)d1 (0)d1 (0)d1 (0)dWilder-Smith et al. (2014)
    SLC10A2 (ASBT/IBAT)16.49 (30)1 (6)4 (6)98.44 (59)98.44 (59)109.18 (59)108.00 (59)1.10 (56)Hruz et al. (2006), Meier et al. (2007), Wojtal et al. (2009), Bourgine et al. (2012), Gröer et al. (2013), Drozdzik et al. (2014)
    SLC15A1 (PEPT1)0.94 (35)1 (20)1.06 (20)1.23 (67)1.23 (67)1.24 (67)1.24 (67)0.03 (63)Ziegler et al. (2002), Englund et al. (2006), Seithel et al. (2006), Meier et al. (2007) Wojtal et al. (2009), Bourgine et al. (2012), Gröer et al. (2013), Oswald et al. (2013), Drozdzik et al. (2014)
    SLC16A1 (MCT1)b1.25 (17)1 (13)1 (13)1.29 (20)1.29 (20)1.29 (20)1.29 (20)4.72 (26)Gill et al. (2005), Englund et al. (2006), Seithel et al. (2006), Bourgine et al. (2012)
    SLCO2B1 (OATP2B1)0.73 (30)1 (20)0.94 (20)1.28 (76)1.28 (76)1.28 (76)1.28 (76)1.06 (58)Englund et al. (2006), Seithel et al. (2006), Meier et al. (2007), Wojtal et al. (2009), Bourgine et al. (2012), Gröer et al. (2013), Oswald et al. (2013), Drozdzik et al. (2014)
    SLCO4C1 (OATP4C1)b1 (0)d1 (0)d1 (0)d1 (3)e1 (3)e1 (3)e1 (3)e1 (3)eBourgine et al. (2012)
    SLC22A1 (OCT1)1.03 (6)1 (6)0.87 (6)1.29 (35)1.29 (35)1.30 (35)1.30 (35)2.77 (32)Wojtal et al. (2009), Bourgine et al. (2012), Gröer et al. (2013), Drozdzik et al. (2014)
    SLC22A3 (OCT3)1.19 (6)1 (6)1.11 (6)1.08 (12)1.08 (12)1.23 (12)1.23 (12)1.88 (9)Bourgine et al. (2012), Gröer et al. (2013), Drozdzik et al. (2014)
    SLC22A4 (OCTN1)b0.46 (16)1 (6)0.63 (6)0.78 (51)0.78 (51)0.80 (51)0.80 (51)0.24 (49)Meier et al. (2007), Wojtal et al. (2009), Bourgine et al. (2012), Girardin et al. (2012), Drozdzik et al. (2014)
    SLC51A/B (OST-α/β)f0.56 (6)1 (6)1.89 (7)1.08 (40)1.08 (40)0.93 (40)0.93 (41)0.71 (6)Renner et al. (2008), Drozdzik et al. (2014), Harwood (2015)
    SLC51B (OST-β)f0.6 (6)1.19 (6)1.16 (9)1.01 (40)1.01 (40)1 (40)1 (41)0.33 (6)Renner et al. (2008), Drozdzik et al. (2014), Harwood (2015)
    • ASBT, apical sodium-dependent bile acid transporter; BCRP, breast cancer resistance protein; MCT1, monocarboxylate transporter 1; PEPT1, peptide transporter 1.

    • ↵a Fixed value of 1: jejunum I was fixed to 1 as the final value; however, prior to normalization a weighted mean relative expression was calculated across samples with the potential for CV generation, hence the sample number provided.

    • ↵b Where only relative abundance data were available.

    • ↵c Final values not updated from those previously reported (Harwood et al., 2013) since the region-specific absolute abundance values in Supplemental Table 3 were similar.

    • ↵d Where samples were not quantified within a given region a relative abundance value of 1 was assumed.

    • ↵e Since there were no jejunum I values available to normalize the ileum and colon abundances to the relative expression for these segments, the value was set to 1.

    • ↵f Used OST-α values from relative and absolute combined analysis—for completeness the OST-β segmental relative abundance values are given in the last row of the table.

Additional Files

  • Figures
  • Tables
  • Data Supplement

    • Supplemental Data -

      4 supplemental tables, methods, and references. 

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 47 (8)
Drug Metabolism and Disposition
Vol. 47, Issue 8
1 Aug 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Regional-Specific Relative and Absolute Expression of Gut Transporters in Adult Caucasians: A Meta-Analysis
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
Citation Tools
Research ArticleArticle

Healthy Adult Caucasian Gut Transporter Abundances

Matthew D. Harwood, Mian Zhang, Shriram M. Pathak and Sibylle Neuhoff
Drug Metabolism and Disposition August 1, 2019, 47 (8) 854-864; DOI: https://doi.org/10.1124/dmd.119.086959

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Healthy Adult Caucasian Gut Transporter Abundances

Matthew D. Harwood, Mian Zhang, Shriram M. Pathak and Sibylle Neuhoff
Drug Metabolism and Disposition August 1, 2019, 47 (8) 854-864; DOI: https://doi.org/10.1124/dmd.119.086959
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • NRF2-Independent Regulation of DMEs by Cadmium and ITCs
  • OATP Uptake in HEK293 Cells with and without Plasma
  • P450 Activities in Paired Liver and Small Intestinal Samples
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics